# Effects of IV Chloride Content on Outcomes

> **NCT02083198** · — · COMPLETED · sponsor: **Baxter Healthcare Corporation** · enrollment: 1558 (actual)

## Conditions studied

- SIRS
- Balanced Fluids
- Plasmalyte

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02083198
- **Lead sponsor:** Baxter Healthcare Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2014-04-01
- **Final completion:** 2014-04-01
- **Target enrollment:** 1558 (ACTUAL)
- **Last updated:** 2017-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02083198

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02083198, "Effects of IV Chloride Content on Outcomes". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02083198. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*